Cargando…
BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma
BACKGROUND: Neuroblastoma (NB) is a common extracranial malignancy with high mortality in children. Recently, super-enhancers (SEs) have been reported to play a critical role in the tumorigenesis and development of NB via regulating a wide range of oncogenes Thus, the synthesis and identification of...
Autores principales: | Chen, Yan-Ling, Li, Xiao-Lu, Li, Gen, Tao, Yan-Fang, Zhuo, Ran, Cao, Hai-Bo, Jiao, Wan-yan, Li, Zhi-Heng, Zhu, Zhen-Hong, Fang, Fang, Xie, Yi, Liao, Xin-Mei, Wu, Di, Wang, Hai-Rong, Yu, Juan-Juan, Jia, Si-Qi, Yang, Yang, Feng, Chen-Xi, Yang, Peng-Cheng, Fei, Xiao-Dong, Wang, Jian-Wei, Xu, Yun-Yun, Qian, Guang-Hui, Zhang, Zi-Mu, Pan, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932231/ https://www.ncbi.nlm.nih.gov/pubmed/35303940 http://dx.doi.org/10.1186/s13578-022-00769-8 |
Ejemplares similares
-
BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia
por: Sang, Xu, et al.
Publicado: (2022) -
An inhibitor of BRD4, GNE987, inhibits the growth of glioblastoma cells by targeting C-Myc and S100A16
por: Ma, Liya, et al.
Publicado: (2022) -
The BRD4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in Neuroblastoma
por: Jia, Si-Qi, et al.
Publicado: (2022) -
Native Mass Spectrometry for the Study of PROTAC GNE‐987‐Containing Ternary Complexes
por: Sternicki, Louise M., et al.
Publicado: (2021) -
SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7
por: Zhang, Zi-Mu, et al.
Publicado: (2022)